Media Coverage

Why do we understand so little about breast-feeding?

Health systems are more likely to thwart the establishment and practice of breast-feeding than to teach it. “The vast majority of hospital staff members can’t provide the education about how to breast-feed just after birth that so many women want, so instead, women receive conflicting advice or none at all,” wrote Malika Shah, an assistant professor at Northwestern University who specializes in breast-feeding medicine.

Limb amputation rates for blocked arteries vary by race and setting

“Although racial bias may play some role, probably much more important is what hospitals and health systems are used by patients of different races,” said Dr. Joe Feinglass of the Northwestern University Feinberg School of Medicine in Chicago, who wasn’t involved in the study

Rating Doctors: What You Need to Know

Look for volume. Surgeons who do a high volume of a specific type of procedure are typically good at that kind of surgery, says Dr. Karl Bilimoria, director of the Surgical Outcomes and Quality Improvement Center at Northwestern Medicine in Chicago. The same principle holds true for nonsurgical physicians who treat a high volume of a particular kind of condition or illness, such as breast cancer, heart disease or diabetes, he says. “The more you do something, the better you are at it.”

‘Guns don’t kill people; men and boys kill people,’ experts say

Before Kelley fired at children and their caregivers in pews, he had been accused of animal cruelty, stalking, sexual assault and beating his wife and 1-year-old stepson, leaving the boy with a fractured skull. “Everything we know about domestic violence predicted this could happen,” said Lori Post, a researcher at Northwestern University’s Feinberg School of Medicine who studies domestic violence.

Amish People Stay Healthy in Old Age. Here’s Their Secret

In a study released last November, researchers at Northwestern University announced the discovery of a gene in an Amish community that seemed to be associated with an average life span 10% longer than that of people without the gene. The long-lived subjects also had 10% longer telomeres–the caps at the end of chromosomes that shorten over time and drive the aging process. The gene, known as PAI-1, is linked not only to slower aging but also to better insulin levels and better blood pressure and arterial flexibility.

Digital divide persists with online portals for cancer patients

“Cancer patients presumably are focused on being healthy, and the patient portal is meant to allow patients to engage deeply in managing their health through looking at results and communicating with their providers,” said Dr. Mita Sanghavi Goel, a researcher at the Feinberg School of Medicine at Northwestern University in Chicago who wasn’t involved in the study. “This study was surprising because it found that there was a trend towards looking at fewer test results over time, even among cancer patients,” Goel said by email. “It raises the question, then, that if cancer patients are less likely to look at their results over time, who would?”

Maryland’s No-Cost Vasectomy Law May Leave Some Patients Behind

Despite the uncertainty around HSAs, Maryland’s law requiring coverage of vasectomies without cost sharing addresses a gap in men’s preventive coverage.

Still, only 7 percent of men ages 18 to 45 have had a vasectomy, according to a 2013 study by researchers at Northwestern University. The prevalence increased to 16 percent among men ages 36 to 45. Men with higher incomes, higher education and a regular source of health care were more likely to have had the procedure, the study found.

Study: Scientists Discover Huntington’s Cancer Weapon

“This molecule is a super assassin against all tumor cells,” said Marcus Peter, the senior author of a study about the findings, in a press release. “We’ve never seen anything this powerful.” Huntington’s disease causes the progressive breakdown of nerve cells in the brain, causing death within 10-30 years, according to the Mayo Clinic. It is caused by an overabundance of a specific type of repeating RNA sequences in one gene, huntingtin, present in every cell. Researchers found the defect that causes the disease is also extremely toxic to tumor cells. The repeating small interfering RNA sequences attack genes in the cell that are crucial for survival.[…]Andrea Murmann, a research assistant professor in medicine at Feinberg and first author of the study, discovered the Huntington’s cancer weapon and used the molecule to treat human and mouse ovarian, breast, prostate, liver, brain, lung, skin and colon cancer cell lines. The molecule killed cancer cells in both species.